Alfresa Holdings Corporation (TYO:2784)
2,158.50
-10.50 (-0.48%)
Oct 21, 2025, 12:42 PM JST
Alfresa Holdings Revenue
Alfresa Holdings had revenue of 758.12 billion JPY in the quarter ending June 30, 2025, with 4.95% growth. This brings the company's revenue in the last twelve months to 3 trillion, up 4.35% year-over-year. In the fiscal year ending March 31, 2025, Alfresa Holdings had annual revenue of 2.96 trillion with 3.59% growth.
Revenue (ttm)
3.00T
Revenue Growth
+4.35%
P/S Ratio
0.13
Revenue / Employee
240.67M
Employees
12,452
Market Cap
394.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 2.96T | 102.55B | 3.59% |
Mar 31, 2024 | 2.86T | 162.43B | 6.02% |
Mar 31, 2023 | 2.70T | 110.43B | 4.27% |
Mar 31, 2022 | 2.59T | -17.53B | -0.67% |
Mar 31, 2021 | 2.60T | -95.34B | -3.53% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Takeda Pharmaceutical Company | 4.48T |
Otsuka Holdings | 2.40T |
Astellas Pharma | 1.94T |
Daiichi Sankyo Company | 1.92T |
Chugai Pharmaceutical | 1.20T |
Terumo | 1.04T |
Olympus | 969.02B |
HOYA Corporation | 876.09B |